A path to a cure for Multiple Sclerosis?

In the last few years, researchers have been making strides in many areas to find a cure. My feeling is that stem cells transplant therapy is the most promising path to a cure. The technique involves using autologous non-myeloablative cells to reset your immune system.  

 

The intention of the procedure is to wipe out the immune system and then, with one’s own cells, reconstitute it with the hope that the new cells will not target myelin. The theory is to get rid of bad cells and reconstitute it with new cells from one’s own body so hopefully they haven’t been triggered yet to attach to myelin. Non-myeloablative autologous haemopoietic stem cell transplantation is intended for patients with relapsing-remitting MS.

 

Between January, 2003, and February, 2005, 21 patients were treated 17 of 21 patients (81%) improved by at least 1 point on the Kurtzke Expanded Disability Status Scale (EDSS), and five patients (24%) relapsed but achieved remission after further immunosuppression. After a mean of 37 months (range24—48 months), all patients were free from progression (no deterioration in EDSS score), and 16 were free of relapses.

 

Early results show Non-myeloablative autologous haemopoietic stem cell transplantation was able to reverses neurological deficits, but these results need to be confirmed in a randomized trial.

 

Studies were initiated by Richard K. Burt, MD, Associate Professor, Division of Immunotherapy Northwestern University Department of Medicine. Please Visit Disability Connections, New Treatment page to watch part 1 and 2 of Dr. Burt’s lecture on Non-myeloablative autologous haemopoietic stem cell transplantation or to learn more, contact Northwestern University Division of Immunotherapy.


Division Address
750 N. Lakeshore Dr., Suite 649
Chicago
, IL60611
(312) 908-0059
(312) 908-0064 Fax

Contact Information

rburt@northwestern.edu

 

 

Source accessed June 21, 2010:

http://www.thelancet.com/journals/lancet/article/PIIS1474-4422%2809%2970017-1/abstract

 

 

What did you think of this article?




Trackbacks
  • No trackbacks exist for this post.
Comments

Leave a comment

Submitted comments are subject to moderation before being displayed.

 Enter the above security code (required)

 Name

 Email (will not be published)

 Website

Your comment is 0 characters limited to 3000 characters.